Animal inhalation studies have reported that adverse pulmonary, cardiovascular, and immune reactions may result from exposure to multi-walled carbon nanotubes (MWCNTs). At the present time, however, there is little guidance for adequate sampling and characterization of MWCNT aerosols for evaluating exposures and obtaining an applicable dose metric for risk assessment. This is mainly because MWCNTs tend to agglomerate and form complex structures making them difficult to characterize. To address this problem, we conducted detailed sampling and characterization studies of MWCNTs that had similar particle morphologies to those found in the workplace. Representative samples were collected using filters, a cascade impactor, and direct reading instruments, and they were used for microscopic observation, gravimetric analysis, and real-time monitoring. Particle number distributions on a filter (0.008-0.10 particles/microm2), and mass distributions using an impactor (0.1-0.3 mg on peak stages) were determined. Microscopic analyses indicated that MWCNTs can be classified into three shape categories: irregular, isometric, and fibrous particle structures. Each particle structure contained a mean of 18 nanotubes, and 1 microg of MWCNTs contained 2.7 x 106 particle structures composed of 4.9 x 107 individual nanotubes. Impactor measurements showed that the mass median aerodynamic diameter of the aerosol was 1.5 microm with a geometric standard deviation of 1.67. The shape factor of individual fibers was 1.94-2.71, and the isometric particles had an effective density of 0.71-0.88 g/cm3. Results also indicated that real-time particle number counts were realistic, but without an index of agglomeration, they were insufficient for adequate risk assessment. Information from this study can be used to estimate initial lung burden and to design an improved lung deposition model that considers three individual MWCNT particle shapes. The described methods can be used as guidance for sampling and characterizing other engineered nanoparticles.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.